News

Eli Lilly-partnered TRexBio will apply the IPO proceeds toward clinical development of molecules designed to activate regulatory T cells to mediate immune responses and inflammation. Meanwhile, Retension Pharmaceuticals will use its IPO cash for mid-stage testing of a next-generation hypertension drug. The post TRrexBio’s IPO Bags $116M to Bring the Immune System Back Into Balance […]

The pace of change in digital innovation has exposed the ever-widening gap between digital health and Pharma commercial teams. As a result, Pharma is missing out on its ability to significantly improve its commercial model, by focusing on efficiencies vs. truly reinventing. The post What Life Sciences Commercial Teams Can Learn from Digital Health appeared […]

Diagnostics and drug development startup Arboretum LifeSciences launched with $30 million in financing. Its executives say analyses of data from its genetic tests both form the basis of partnerships with big pharma and lead to the formation of new biotech companies — all focused on common diseases. The post Startup Arboretum Sprouts, Bringing a Precision […]

The Series A round was led by Oak HC/FT, with participation from Norwest, .406 Ventures, Constellation Ventures, Y Combinator, Rock Health Capital and MemorialCare Innovation Fund.  The post Vitalize Secures $31M To Help Hospitals Manage Labor, Capacity appeared first on MedCity News.

Earlier detection is valuable, but it creates a duty that does not end when an alert appears in the electronic health record. Health systems need to decide, in advance, how a risk signal becomes a clinically accountable pathway. The post AI Can Flag Cognitive Decline Earlier — Health Systems Still Own What Happens Next appeared […]

Trilliant Health’s report identifies six trends highlighting how misaligned incentives are contributing to rising costs, poor health outcomes, workforce shortages and other systemic problems in U.S. healthcare. The post Trilliant Health: Misaligned Incentives Are Undermining US Healthcare appeared first on MedCity News.

Teladoc Health announced Wednesday that it is launching two new AI-powered capabilities built into its Solo smart care platform for hospitals and health systems to be used during virtual visits. The post Teladoc Health Adds Contactless Vitals and Ambient AI Scribe to Virtual Visit Platform appeared first on MedCity News.

Caribou Biosciences is stopping work on its two remaining cancer cell therapies and exploring strategic alternatives for the business. The move follows the CRISPR biotech company’s failure to secure financing for its clinical trial plans. The post Caribou Bio’s Journey With Off-the-Shelf Cell Therapy Reaches the End of the Road appeared first on MedCity News.

[Sponsored] Sponsored by Cotiviti, a webinar addressing the challenges of AI implementation and governance offered insights based on findings from the Healthcare AI Readiness Index. The post Constant Vigilance is the Watchword for Healthcare AI Governance  appeared first on MedCity News.

Employers are trying to comparison shop in a market where all the price tags are hidden. And most can’t simply switch PBMs to find better pricing for their members. The post PBM Transparency Is Still Too Opaque — How Can Employers Rein In Drug Costs? appeared first on MedCity News.

No longer satisfied with buying pharmacies and clinics, it seems intent on owning the healthcare journey, and perhaps redrawing pharma’s commercialization map. The post From Distributor to Disruptor: Amazon’s Healthcare Flex appeared first on MedCity News.

Cybersecurity leaders discussed how AI-driven cybersecurity attacks pose a new level of risk for hospitals and health systems at Rubrik’s Healthcare Summit last week. The post Cybersecurity Experts to Hospital Leaders: Think Beyond Traditional Disaster-Recovery Planning appeared first on MedCity News.

The FTC sent warning letters to 24 major healthcare organizations over concerns about inadequate price transparency. The post FTC Sends Warning Letters to 24 Healthcare Organizations Over Price Transparency appeared first on MedCity News.

Forbion’s new capital will support two funds that will invest in about 30 companies combined. The new funds for Netherlands-based Forbion come amid a decline in VC fundraising and investments in Europe, according to Pitchbook. The post Forbion Bucks VC Fundraising Trends, Reeling In €2.3B for Two New Funds appeared first on MedCity News.

Perimenopausal anxiety isn’t simply in our patients’ heads. It’s often the result of complex physiologic changes involving hormones, sleep, metabolism, and the nervous system. The post Perimenopause Anxiety: Sometimes It’s a Progesterone Deficiency appeared first on MedCity News.

I kept hearing “medtech VC is in decline,” so I decided to dig into the data myself. I expected shrinking investor interest, inflated valuations, and a weak exit environment. Instead, I found a more nuanced story. The post MedTech VC 2026: The Real Story vs. The Thesis appeared first on MedCity News.

[Sponsored] A new report from ProgenyHealth offers a window into how the business works with commercial and Medicaid plans to close gaps in maternity and NICU care management that traditional programs overlook. The post Hidden Risks and Costs of Maternal/Infant Health that Health Plans Miss appeared first on MedCity News.

Launched last week, Facktor Ventures, an early-stage venture fund is taking a new approach to healthcare investing: they’re structured so that the organizations delivering care on the ground collectively become majority owners of the fund as limited partners. The post Investing in Community Health: A New Model for Safety-Net Healthcare Innovation appeared first on MedCity […]

Shionogi’s IntraBio acquisition brings Aqneursa, a drug approved for treating two rare neurological disorders and the potential to expand to additional indications, both rare and common. It’s Shionogi’s second big rare disease move this year, following the acquisition of global rights to an amyotrophic lateral sclerosis drug from Tanabe Pharma. The post Shionogi Adds to […]

The Trump administration is issuing one-time $90 payments to more than 20 million Medicare beneficiaries to help cover Part B premiums, though the payments may do little to offset rising healthcare costs. The post Trump Administration Announces $90 Payments to Help Cover Medicare Part B Premiums appeared first on MedCity News.